BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 28633036)

  • 1. Recent advances in understanding multiple myeloma.
    Hari P
    Hematol Oncol Stem Cell Ther; 2017 Dec; 10(4):267-271. PubMed ID: 28633036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in understanding multiple myeloma.
    Dhakal B; Girnius S; Hari P
    F1000Res; 2016; 5():. PubMed ID: 27610224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allogeneic stem cell transplantation for multiple myeloma: is there a future?
    Dhakal B; Vesole DH; Hari PN
    Bone Marrow Transplant; 2016 Apr; 51(4):492-500. PubMed ID: 26726943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in the autologous and allogeneic transplantation strategies for multiple myeloma.
    Nishihori T; Alsina M
    Cancer Control; 2011 Oct; 18(4):258-67. PubMed ID: 21976244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How is patient care for multiple myeloma advancing?
    Genadieva Stavric S; Bonello F; Bringhen S; Boccadoro M; Larocca A
    Expert Rev Hematol; 2017 Jun; 10(6):551-561. PubMed ID: 28504554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular immunotherapy as a therapeutic approach in multiple myeloma.
    Liegel J; Avigan D; Rosenblatt J
    Expert Rev Hematol; 2018 Jul; 11(7):525-536. PubMed ID: 29856648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular and vaccine immunotherapy for multiple myeloma.
    Garfall AL; Stadtmauer EA
    Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):521-527. PubMed ID: 27913524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of multiple myeloma in the newly diagnosed patient.
    Mateos MV; San Miguel JF
    Hematology Am Soc Hematol Educ Program; 2017 Dec; 2017(1):498-507. PubMed ID: 29222298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beyond consolidation: auto-SCT and immunotherapy for plasma cell myeloma.
    Lendvai N; Cohen AD; Cho HJ
    Bone Marrow Transplant; 2015 Jun; 50(6):770-80. PubMed ID: 25751647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of high-dose chemotherapy in the treatment of multiple myeloma: a controversy.
    Kyle RA
    Ann Oncol; 2000; 11 Suppl 1():55-8. PubMed ID: 10707780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The most recent developments in diagnosis and treatment of multiple myeloma].
    Jurczyszyn A; Olszewska-Szopa M
    Przegl Lek; 2017; 74(1):30-6. PubMed ID: 29693999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-mediated and cellular immunotherapy in multiple myeloma.
    Ritchie DS; Quach H; Fielding K; Neeson P
    Immunotherapy; 2010 Mar; 2(2):243-55. PubMed ID: 20635931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of relapsed multiple myeloma after autologous stem cell transplant.
    Holstein SA; Richardson PG; Laubach JP; McCarthy PL
    Biol Blood Marrow Transplant; 2015 May; 21(5):793-8. PubMed ID: 25652690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of multiple myeloma.
    San Miguel JF; Bladé Creixenti J; García-Sanz R
    Haematologica; 1999 Jan; 84(1):36-58. PubMed ID: 10091392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of stem cell transplant and maintenance therapy in plasma cell disorders.
    McCarthy PL; Holstein SA
    Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):504-511. PubMed ID: 27913522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kidney Transplant in the Era of Modern Therapy for Multiple Myeloma.
    Huskey JL; Heilman RL; Khamash H; Fonseca R
    Transplantation; 2018 Dec; 102(12):1994-2001. PubMed ID: 30211830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging options in multiple myeloma: targeted, immune, and epigenetic therapies.
    Kumar S
    Hematology Am Soc Hematol Educ Program; 2017 Dec; 2017(1):518-524. PubMed ID: 29222300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple myeloma : recent progress in diagnosis and treatment.
    Chou T
    J Clin Exp Hematop; 2012; 52(3):149-59. PubMed ID: 23269074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding biology to tackle the disease: Multiple myeloma from bench to bedside, and back.
    Bianchi G; Anderson KC
    CA Cancer J Clin; 2014; 64(6):422-44. PubMed ID: 25266555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The emerging role of consolidation and maintenance therapy for transplant-eligible multiple myeloma patients.
    McCarthy PL; Einsele H; Attal M; Giralt S
    Expert Rev Hematol; 2014 Feb; 7(1):55-66. PubMed ID: 24471885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.